J Epidemiol Community Health

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
Journal of Epidemiology and Community Health 2005;59:713
Copyright © 2005 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ashton, J. R
Right arrow Articles by Alvarez-Dardet, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ashton, J. R
Right arrow Articles by Alvarez-Dardet, C.
Topic Collections
Right arrowRelated Articles

An interdisciplinary analysis of the hormone replacement therapy saga

John R Ashton, Carlos Alvarez-Dardet, Joint Editors

The first 150 words of the full text of this article appear below.


AN INTERDISCIPLINARY ANALYSIS OF THE HORMONE REPLACEMENT THERAPY SAGA
In this issue we publish an unusual, albeit very much needed, approach to the HRT debate. An international and interdisciplinary team have put together their expertise from the historical, epidemiological, biological, clinical, and advocacy perspectives. Nancy Krieger and her colleagues ask in their paper an undoubtedly crucial question: why, since the mid-1960s, were millions of women prescribed powerful pharmacological agents that had already been shown, three decades earlier, to be carcinogenic?

To understand the eventual answer to this question, they identify in the HRT process a series of missing elements, like for example the invisible industrialist, regulatory agencies and public compared with private interests, beliefs regarding individual compared with collective risk, the irresistible growth of individualised ‘‘preventive medicine", and the gendering of hormones and regulation of women’s sexuality.

To avoid the occurrence of similar iatrogenic disasters in the future, Krieger and colleagues call for greater transparency with regard to the . . . [Full text of this article]


Related Articles

Who cares about health for all in the 21st century?
Fran Baum
J. Epidemiol. Community Health 2005 59: 714-715. [Extract] [Full Text] [PDF]

Geographically based approaches can identify environmental causes of disease
Manolis Kogevinas and Neil Pearce
J. Epidemiol. Community Health 2005 59: 717-718. [Extract] [Full Text] [PDF]

Hormone replacement therapy, cancer, controversies, and women’s health: historical, epidemiological, biological, clinical, and advocacy perspectives
Nancy Krieger, Ilana Löwy, Robert Aronowitz, Judyann Bigby, Kay Dickersin, Elizabeth Garner, Jean-Paul Gaudillière, Carolina Hinestrosa, Ruth Hubbard, Paula A Johnson, Stacey A Missmer, Judy Norsigian, Cynthia Pearson, Charles E Rosenberg, Lynn Rosenberg, Barbara G Rosenkrantz, Barbara Seaman, Carlos Sonnenschein, Ana M Soto, Joe Thornton, and George Weisz
J. Epidemiol. Community Health 2005 59: 740-748. [Abstract] [Full Text] [PDF]

Oil combustion and childhood cancers
E G Knox
J. Epidemiol. Community Health 2005 59: 755-760. [Abstract] [Full Text] [PDF]

Income distribution, public services expenditures, and all cause mortality in US states
James R Dunn, Bill Burgess, and Nancy A Ross
J. Epidemiol. Community Health 2005 59: 768-774. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.